Vivani Medical (VANI) EBITDA Margin (2014 - 2022)
Vivani Medical (VANI) reported EBITDA Margin of -239.00% for Q1 2022, down 62.56 percentage points from -176.44% a year earlier.
Powered by 
Analysis
Vivani Medical (VANI) EBITDA Margin (2014 - 2022) Analysis & Trends
For FY2019, Vivani Medical posted EBITDA Margin of -993.10%, down 489.55 percentage points from FY2018.
- EBITDA Margin has a four-year change of -772.86 percentage points (FY2015 to FY2019).
- By year, EBITDA Margin came in at -503.55% in FY2018 (-150.06 pp), -353.49% in FY2017 (+469.04 pp), -822.53% in FY2016 (-602.29 pp) and -220.25% in FY2015.
- Five-year quarterly EBITDA Margin spans a low of -203875.00% in Q3 2021 and a high of -98.75% in Q3 2020.
- Year over year, EBITDA Margin gained in two of the last four quarters, with an average year-over-year change of -50492.62 percentage points.
- The high point for year-over-year EBITDA Margin in five years was Q3 2020 (a gain of 1494.89 percentage points); the low point was Q3 2021 (a drop of 203776.25 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 39.10% |
| 10 | Vivani Medical | 110.87 Mn | 52.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | -239.00% |
| Sep 30, 2021 | -203,875.00% |
| Mar 31, 2021 | -176.44% |
| Sep 30, 2020 | -98.75% |
| Mar 31, 2020 | -549.88% |
| Dec 31, 2019 | -1,614.08% |
| Sep 30, 2019 | -1,593.64% |
| Jun 30, 2019 | -650.86% |
| Mar 31, 2019 | -857.18% |
| Dec 31, 2018 | -496.38% |
| Sep 30, 2018 | -375.73% |
| Jun 30, 2018 | -413.06% |
| Mar 31, 2018 | -989.55% |
| Dec 31, 2017 | -235.48% |
| Sep 30, 2017 | -411.99% |
| Jun 30, 2017 | -302.15% |
| Mar 31, 2017 | -737.56% |
| Dec 31, 2016 | -1,435.24% |
| Sep 30, 2016 | -711.10% |
| Jun 30, 2016 | -800.78% |
API Access
Vivani Medical EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=VANI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "VANI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=VANI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();